Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Hypertension, Grade 2”

98 trials

Showing 20 of 98 results

Post-approval studies (Phase 4)Study completedNCT02495324
What this trial is testing

Fimasartan Achieving SBP Target (FAST) Study

Who this might be right for
Essential,Hypertension
Boryung Pharmaceutical Co., Ltd 369
Not applicableStudy completedNCT01560975
What this trial is testing

IOP Fluctuations in Patients With Sleep Apnea With or Without Primary Open Angle Glaucoma Using Positive Airway Pressure

Who this might be right for
Sleep Apnea, ObstructivePrimary Open-angle Glaucoma
Sensimed AG 10
Testing effectiveness (Phase 2)Study completedNCT05593562
What this trial is testing

Study on Human Mass Balance of SPH3127 Tablets

Who this might be right for
Primary Mild and Moderate Hypertension
Shanghai Pharmaceuticals Holding Co., Ltd 6
Large-scale testing (Phase 3)Study completedNCT00392262
What this trial is testing

Evaluate the Combination of Valsartan + Amlodipine in Hypertensive Patients

Who this might be right for
Hypertension
Novartis 224
Not applicableStudy completedNCT07375407
What this trial is testing

Aerobic Exercise vs Physiological Ischemic Training in Stage 2 Hypertension

Who this might be right for
Primary Hypertension, Grade 2
Universitas Padjadjaran 60
Post-approval studies (Phase 4)Study completedNCT00302705
What this trial is testing

Comparison of the Antihypertensive Efficacy of Valsartan and Enalapril After Missing One Dose

Who this might be right for
Hypertension
University of Vigo 150
Large-scale testing (Phase 3)Study completedNCT01631227
What this trial is testing

Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Essential Hypertension

Who this might be right for
Essential Hypertension
Abbott 665
Testing effectiveness (Phase 2)Study completedNCT00710372
What this trial is testing

Safety, Tolerability and Efficacy of a Vaccine Against Essential Hypertension

Who this might be right for
Mild Essential HypertensionModerate Essential Hypertension
Cytos Biotechnology AG 83
Testing effectiveness (Phase 2)UnknownNCT05033535
What this trial is testing

S086 Tablets in the Treatment of Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Shenzhen People's Hospital 10
Large-scale testing (Phase 3)Study completedNCT02206659
What this trial is testing

Effects of Telmisartan by Ambulatory Blood Pressure Monitoring (ABPM) in Chinese Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 20
Large-scale testing (Phase 3)Study completedNCT01456169
What this trial is testing

Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone

Who this might be right for
Essential Hypertension
Takeda 507
Testing effectiveness (Phase 2)Study completedNCT01303783
What this trial is testing

Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension

Who this might be right for
Hypertension, Essential
Bayer 1,381
Large-scale testing (Phase 3)Study completedNCT00857285
What this trial is testing

Olmesartan Medoxomil Versus Losartan in Patients With Hypertension

Who this might be right for
Essential Hypertension
Daiichi Sankyo 130
Large-scale testing (Phase 3)Study completedNCT00257491
What this trial is testing

Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 29
Not applicableEnded earlyNCT05583591
What this trial is testing

Combined Phacoemulsification With iStent Inject W Versus Hydrus for Mild to Moderate Open Angle Glaucoma

Who this might be right for
Open Angle Glaucoma
Diablo Eye Associates 58
Testing effectiveness (Phase 2)Study completedNCT03756103
What this trial is testing

Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients

Who this might be right for
Hypertension,Essential
Shanghai Pharmaceuticals Holding Co., Ltd 120
Large-scale testing (Phase 3)Not Yet RecruitingNCT06716970
What this trial is testing

QR12000 Compound Tablets in Patients with Moderate to Severe Essential Hypertension

Who this might be right for
Essential Hypertension
Wuhan Createrna Science and Technology Co., Ltd 810
Post-approval studies (Phase 4)Study completedNCT00328965
What this trial is testing

Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea

Who this might be right for
Diabetes Mellitus, Type 2Essential Hypertension
GlaxoSmithKline
Large-scale testing (Phase 3)Study completedNCT01033071
What this trial is testing

Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.

Who this might be right for
Essential Hypertension
Takeda 1,071
Not applicableStudy completedNCT00218972
What this trial is testing

Physical Exercise in Hypertension, Randomised Clinical Trial

Who this might be right for
Hypertension
Norwegian University of Science and Technology 88
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation